thiazoles has been researched along with rifamycins in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Kamiya, S; Taguchi, H | 1 |
| Bronze, MS; Greenfield, R; Greenfield, RA; Salvaggio, M; Sud, B | 1 |
| Alexiev, A; Grigorova, G; Lyapova, A; Petrov, G; Raykov, ZZ; Vassilev, K | 1 |
| Finegold, SM; Molitoris, D; Väisänen, ML | 1 |
| Cabada, MM; Pantenburg, B; White, AC | 1 |
| Dziędgiel, P; Gomułkiewicz, A; Magdalan, J; Ostrowska, A; Piotrowska, A; Szeląg, A | 1 |
| Dang, MD; DuPont, HL; Garey, KW; Hasbun, R; Jiang, ZD; Koo, HL; Shah, D | 1 |
| Johnson, S; Soriano, MM | 1 |
| Abd-Elsalam, SM; Glal, KAM; Mostafa, TM | 1 |
5 review(s) available for thiazoles and rifamycins
| Article | Year |
|---|---|
[Prospect of the development of new bactericidal drugs against Helicobacter pylori for eradication therapy].
Topics: Animals; Anti-Bacterial Agents; Benzenesulfonates; Carbapenems; Cetylpyridinium; Drug Design; Drug Resistance, Bacterial; Ellagic Acid; Fish Oils; Food Analysis; Glycyrrhizic Acid; Helicobacter Infections; Helicobacter pylori; Nitrofurantoin; Rifamycins; Thiazoles | 2002 |
Part XI. Trimethoprim-sulfamethoxazole, nitrofurantoin, chloramphenicol, metronidazole and tinidazole, rifaximin, and nitazoxanide.
Topics: Anti-Bacterial Agents; Bacterial Infections; Chloramphenicol; Drug Resistance, Microbial; Humans; Metronidazole; Nitro Compounds; Nitrofurantoin; Rifamycins; Rifaximin; Thiazoles; Tinidazole; Trimethoprim, Sulfamethoxazole Drug Combination | 2007 |
Treatment of cryptosporidiosis.
Topics: AIDS-Related Opportunistic Infections; Animals; Antiretroviral Therapy, Highly Active; Azithromycin; Biliary Tract Diseases; Coccidiostats; Cryptosporidiosis; Humans; Immunocompromised Host; Nitro Compounds; Paromomycin; Rifamycins; Rifaximin; Thiazoles | 2009 |
Clostridium difficile infection: update on emerging antibiotic treatment options and antibiotic resistance.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clinical Trials, Phase III as Topic; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Fidaxomicin; Humans; Microbial Sensitivity Tests; Nitro Compounds; Randomized Controlled Trials as Topic; Rifamycins; Rifaximin; Thiazoles; Treatment Outcome | 2010 |
Treatment of Clostridium difficile infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Administration Schedule; Drug Therapy, Combination; Fidaxomicin; Gastrointestinal Diseases; Humans; Metronidazole; Nitro Compounds; Randomized Controlled Trials as Topic; Recurrence; Rifamycins; Rifaximin; Thiazoles; Vancomycin | 2015 |
1 trial(s) available for thiazoles and rifamycins
| Article | Year |
|---|---|
Nitazoxanide versus rifaximin in preventing the recurrence of hepatic encephalopathy: A randomized double-blind controlled trial.
Topics: Child; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Nitro Compounds; Prospective Studies; Quality of Life; Rifamycins; Rifaximin; Thiazoles | 2021 |
3 other study(ies) available for thiazoles and rifamycins
| Article | Year |
|---|---|
Spin-labeled rifamycin: biological activity.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Cell Line, Tumor; Cell Survival; Female; Gamma Rays; Humans; Indicators and Reagents; Magnetic Resonance Spectroscopy; Male; Mice; Microbial Sensitivity Tests; Oxidative Stress; Rifamycins; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Spin Labels; Tetrazolium Salts; Thiazoles | 2008 |
Study of the in vitro activities of rifaximin and comparator agents against 536 anaerobic intestinal bacteria from the perspective of potential utility in pathology involving bowel flora.
Topics: Ampicillin; Bacteria, Anaerobic; Feces; Microbial Sensitivity Tests; Neomycin; Nitro Compounds; Rifamycins; Rifaximin; Sulbactam; Teicoplanin; Thiazoles; Vancomycin | 2009 |
Comparative antidotal efficacy of benzylpenicillin, ceftazidime and rifamycin in cultured human hepatocytes intoxicated with α-amanitin.
Topics: Alpha-Amanitin; Anti-Bacterial Agents; Antidotes; Ceftazidime; Cell Survival; Cells, Cultured; Hepatocytes; Humans; L-Lactate Dehydrogenase; Mushroom Poisoning; Penicillin G; Rifamycins; Tetrazolium Salts; Thiazoles | 2009 |